Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1160717.RAyq8vzM235hrsOR7SB4hlgHw39REpZYhe1t6qP4-NwLY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1160717.RAyq8vzM235hrsOR7SB4hlgHw39REpZYhe1t6qP4-NwLY130_assertion type Assertion NP1160717.RAyq8vzM235hrsOR7SB4hlgHw39REpZYhe1t6qP4-NwLY130_head.
- NP1160717.RAyq8vzM235hrsOR7SB4hlgHw39REpZYhe1t6qP4-NwLY130_assertion description "[In the pleiotropy analysis, six risk variants for other cancers were associated with NHL risk, including variants for lung (rs401681 in TERT: OR per C allele=0.89, p=3.7 � E-03; rs4975616 in TERT: OR per A allele=0.90, p=0.01; rs3131379 in MSH5: OR per T allele=1.16, p=0.03), prostate (rs7679673 in TET2: OR per C allele=0.89, p=5.7 � E-03; rs10993994 in MSMB: OR per T allele=1.09, p=0.04), and breast (rs3817198 in LSP1: OR per C allele=1.12, p=0.01) cancers, but none of these associations remained significant after multiple test correction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1160717.RAyq8vzM235hrsOR7SB4hlgHw39REpZYhe1t6qP4-NwLY130_provenance.
- NP1160717.RAyq8vzM235hrsOR7SB4hlgHw39REpZYhe1t6qP4-NwLY130_assertion evidence source_evidence_literature NP1160717.RAyq8vzM235hrsOR7SB4hlgHw39REpZYhe1t6qP4-NwLY130_provenance.
- NP1160717.RAyq8vzM235hrsOR7SB4hlgHw39REpZYhe1t6qP4-NwLY130_assertion SIO_000772 24598796 NP1160717.RAyq8vzM235hrsOR7SB4hlgHw39REpZYhe1t6qP4-NwLY130_provenance.
- NP1160717.RAyq8vzM235hrsOR7SB4hlgHw39REpZYhe1t6qP4-NwLY130_assertion wasDerivedFrom befree-2016 NP1160717.RAyq8vzM235hrsOR7SB4hlgHw39REpZYhe1t6qP4-NwLY130_provenance.
- NP1160717.RAyq8vzM235hrsOR7SB4hlgHw39REpZYhe1t6qP4-NwLY130_assertion wasGeneratedBy ECO_0000203 NP1160717.RAyq8vzM235hrsOR7SB4hlgHw39REpZYhe1t6qP4-NwLY130_provenance.